WALTHAM, Mass., January 06, 2026--(BUSINESS WIRE)--BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more Why read AI predictions from ...
In its first year, Dyna released its breakthrough DYNA-1 foundation model, achieved a 99+% success rate in 24-hour non-stop operation, and proved commercial viability through customer deployments.
VICTORIA, British Columbia--(BUSINESS WIRE)-- IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an artificial intelligence-driven biotherapeutic research and technology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results